市場調査レポート
商品コード
1226744
ドレナージカテーテルの世界市場:現状分析と予測(2022年~2028年)Global Drainage Catheters Market: Current Analysis and Forecast (2022-2028) |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ドレナージカテーテルの世界市場:現状分析と予測(2022年~2028年) |
出版日: 2023年01月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 152 Pages
納期: 即日から翌営業日
|
世界のドレナージカテーテルの市場規模は、予測期間中に約5%のCAGRで成長すると予測されています。外科手術の件数の増加、血管の閉塞や破裂につながる神経血管性脳卒中の増加、技術の進歩、ドレナージ処置を補助するための製品の発売の増加は、市場の成長を促進しています。
当レポートでは、世界のドレナージカテーテル市場について調査しており、市場の洞察、市場動向、競合シナリオ、企業概要など、包括的な情報を提供しています。
The drainage catheters are the tubes that are used to remove the access body fluids from the body during the drainage procedure. The blood or body fluid accumulates inside some cavities after surgery or infections, and this fluid's drainage becomes necessary as it can damage surrounding tissues or organs. The rising number of surgical procedures and the growing number of patients with post-surgical complications attributes to the market growth of drainage catheters. For instance, as per Eurostat, at least 1.12 million cesarean sections were performed in the EU in 2020. Furthermore, the increasing number of neurovascular strokes that leads to blockage and bursting of blood vessels are the important reasons for the significant market growth of drainage catheters.
The Drainage Catheters Market is expected to grow at a steady rate of around 5% owing to increasing surgical procedures, technological advancements, and frequent product launches for assisting drainage procedures. For instance, in August 2021, Argon Medical Devices, Inc., announced the commercial launch of SKATER™ Mini-Loop Drainage Catheters in the United States and the European Union.
Based on the product type, the market has been categorized into J-tip, standard loop, and tight loop. Among them, the J-tip segment holds a considerable share of the market. The J-tip drainage catheters are easy to insert and are resistant to blockage are the important factors catalyzing the significant share of the segment in the drainage catheter market.
Based on the application, the market has been categorized into chest drainage catheters, external ventricular drainage catheters, cerebrospinal fluid drainage catheters, and others. Among them, the external ventricular drainage catheters segment holds a significant share of the market. The rising prevalence of neurological disorders is an important factor in the growth of the segment. For instance, as per the WHO, the deaths caused by neurological conditions accounted for 533,172 in the American region.
Based on the end-user, the market has been categorized into hospitals, specialty clinics, ambulatory surgical centers, and others. Among them, the hospital category is to witness higher adoption of drainage catheters during the forecast period. The increasing hospitalization and rising number of post-surgery complications among hospitals are the important reasons for the segmental growth of the hospitals in the drainage catheters market.
For a better understanding of the market adoption of the drainage catheters industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated to hold a dominant share in market share during the forecast period. This is mainly due to the increasing presence of well-established market players in the region, advancements in cell therapy, and the growing population with an increasing number of cancer cases. For instance, according to the American Cancer Society (CMS), in 2022, around 99,780 new melanomas will be diagnosed (about 57,180 in men and 42,600 in women). About 7,650 people are expected to die of melanoma in the U.S.
Some of the major players operating in the market are ICU Medical, Inc; SORIN CORPORATION; Argon Medical Devices, Inc.; MedizinTechnik GmbH & Co. KG; Teleflex Incorporated; Medtronic; Redax S.p.a.; Medela AG.; PAHSCO; and Cook.